すいがん診断におけるしゅようマーカーの有用性  多変量的解析による診断能向上の試み

書誌事項

タイトル別名
  • Studies on the methods of diagnosing pancreatic cancer with the use of tumor markers by discriminant analysis.
  • 多変量的解析による診断能向上の試み

抄録

Although several tumor markers have been evaluated for the diagnosis of pancreatic cancer, there is no single marker that is adequate for diagnosis of pancreatic cancer. We have therefore attempted to differentiate cases of pancreatic cancer from chronic pancreatitis or normal subjects by the combined use of 13 kinds of pancreatic cancer markers determined in the same serum samples. A total of 100 samples were obtained from 50 patients with parcreatic cancer, 20 with chronic pancreatitis and 30 normal subjects. When only a single marker was employed, the best marker for the diagnosis of pancreatic cancer was CA19-9, while with combination assay the combination of CA19-9, TPA, ferritin and α1-AT, was found to be superior, but the diagnostic specificity of these markers was limited. Using discriminant analysis, CEA, α1-AT, ferritin and CA19-9 were weighted and the discriminant eqation y=-13.5+0.32ln (CEA)+0.32ln (ferritin)+1.83ln (α1-AT)+0.20ln (CA19-9) was derived. This equation was found to have 95% accuracy rate in distinguishing cases of pancreatic cancer from chronic pancreatitis or normal subjects. Furthermore, by adopting this equation in other patients with gastrointestinal cancers, we found it to have adequate organ specificity except for periampullary cancer. From this results, it may be concluded that the discriminant equation involving CEA, α1-AT, ferritin and CA19-9 is useful for the diagnosis of pancreatic cancer.

収録刊行物

詳細情報 詳細情報について

  • CRID
    1390282681372027008
  • NII論文ID
    130001064545
  • DOI
    10.11405/nisshoshi1964.82.1731
  • ISSN
    13497693
    04466586
  • PubMed
    3878419
  • 本文言語コード
    ja
  • データソース種別
    • JaLC
    • PubMed
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ